Our babies, during the painful phase of their first teeth emerging (5 to 6 months old), go through unpleasant but necessary episodes, as do their parents—especially their mothers—with pain, fevers, crying, and often sleepless nights, causing total discomfort and disruption for
Innovative formulation combining oral asepsis support with enzymes that break down residual sugar molecules in the mouth of children, who naturally consume sweets; as a result, it significantly reduces cariogenic effects by eliminating one of the three factors that form plaque, thereby promoting, in addition to
Diseases of the oral cavity, also called stomatological diseases, are often underestimated. Yet, they can significantly impact quality of life: pain, bad breath, bleeding, inflammation, and even tooth loss in advanced cases. One of the main causes? The proliferation of pathogenic bacteria in the mouth. Faced with these issues,
The oral cavity is a sensitive environment, often exposed to infections, inflammations, or trauma related to dental procedures. These situations require specific, targeted, and highly effective care. It is in this context that STODERMA Laboratories developed PAROSEPT®, a complete range of products formulated with 0.2% Chlorhexidine DG and Enoxolone.
The mouth is a reflection of our overall health. Yet, it is exposed daily to many aggressions: plaque buildup, bacterial growth, cavities, gingivitis, bad breath… To address these issues, STODERMA Laboratories developed KLOREX®, a complete oral care range based on two antiseptics from
Error. No feed found.
Please go to the Instagram Feed settings page to connect your account.